Follow
Dana Selley
Dana Selley
Professor of Pharmacology and Toxicology, Virginia Commonwealth University
Verified email at vcuhealth.org
Title
Cited by
Cited by
Year
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
JZ Long, W Li, L Booker, JJ Burston, SG Kinsey, JE Schlosburg, FJ Pavón, ...
Nature chemical biology 5 (1), 37-44, 2009
9442009
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
JE Schlosburg, JL Blankman, JZ Long, DK Nomura, B Pan, SG Kinsey, ...
Nature neuroscience 13 (9), 1113-1119, 2010
6172010
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S] thio]-triphosphate binding
LJ Sim, DE Selley, SR Childers
Proceedings of the National Academy of Sciences 92 (16), 7242-7246, 1995
5121995
Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New …
JW Huffman, G Zengin, MJ Wu, J Lu, G Hynd, K Bushell, ALS Thompson, ...
Bioorganic & medicinal chemistry 13 (1), 89-112, 2005
3322005
An essential role for ΔFosB in the nucleus accumbens in morphine action
V Zachariou, CA Bolanos, DE Selley, D Theobald, MP Cassidy, MB Kelz, ...
Nature neuroscience 9 (2), 205-211, 2006
3062006
RGS9 modulates dopamine signaling in the basal ganglia
Z Rahman, J Schwarz, SJ Gold, V Zachariou, MN Wein, KH Choi, ...
Neuron 38 (6), 941-952, 2003
3042003
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S] GTPgammaS autoradiography in rat brain
LJ Sim, DE Selley, SI Dworkin, SR Childers
Journal of Neuroscience 16 (8), 2684-2692, 1996
3011996
Essential role for RGS9 in opiate action
V Zachariou, D Georgescu, N Sanchez, Z Rahman, R DiLeone, O Berton, ...
Proceedings of the National Academy of Sciences 100 (23), 13656-13661, 2003
2742003
Distinct patterns of ΔFosB induction in brain by drugs of abuse
LI Perrotti, RR Weaver, B Robison, W Renthal, I Maze, S Yazdani, ...
Synapse 62 (5), 358-369, 2008
2392008
Cannabinoid receptor agonist efficacy for stimulating [35S] GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
CS Breivogel, DE Selley, SR Childers
Journal of Biological Chemistry 273 (27), 16865-16873, 1998
2111998
μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy
DE Selley, LJ Sim, R Xiao, Q Liu, SR Childers
Molecular pharmacology 51 (1), 87-96, 1997
2061997
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles
JW Huffman, PV Szklennik, A Almond, K Bushell, DE Selley, H He, ...
Bioorganic & Medicinal Chemistry Letters 15 (18), 4110-4113, 2005
1902005
Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S] GTPγS binding in mMOR-CHO cells and rat thalamus
DE Selley, Q Liu, SR Childers
Journal of Pharmacology and Experimental Therapeutics 285 (2), 496-505, 1998
1871998
Differences in G-protein activation by μ-and δ-opioid, and cannabinoid, receptors in rat striatum
LJ Sim, DE Selley, R Xiao, SR Childers
European journal of pharmacology 307 (1), 97-105, 1996
1851996
Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain
LJ Sim-Selley, DE Selley, LJ Vogt, SR Childers, TJ Martin
Journal of Neuroscience 20 (12), 4555-4562, 2000
1712000
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and …
JC Kalvass, ER Olson, MP Cassidy, DE Selley, GM Pollack
Journal of Pharmacology and Experimental Therapeutics 323 (1), 346-355, 2007
1662007
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and …
JC Kalvass, ER Olson, MP Cassidy, DE Selley, GM Pollack
Journal of Pharmacology and Experimental Therapeutics 323 (1), 346-355, 2007
1662007
Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9‐tetrahydrocannabinol exposure
JJ Burston, JL Wiley, AA Craig, DE Selley, LJ Sim‐Selley
British journal of pharmacology 161 (1), 103-112, 2010
1532010
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1–mediated antinociceptive and gastroprotective effects
SG Kinsey, LE Wise, D Ramesh, R Abdullah, DE Selley, BF Cravatt, ...
Journal of Pharmacology and Experimental Therapeutics 345 (3), 492-501, 2013
1492013
CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a
JL Niehaus, Y Liu, KT Wallis, M Egertová, SG Bhartur, S Mukhopadhyay, ...
Molecular pharmacology 72 (6), 1557-1566, 2007
1412007
The system can't perform the operation now. Try again later.
Articles 1–20